The HCPLive conference coverage page features articles, videos, and expert-led live coverage from major medical meetings throughout the year.
JP Llanos Ackert, MD, C Ambrose, MD: New Data Support Tezepelumab for AsthmaMay 31st 2023
Investigators Dr. Jean-Pierre Llanos Ackert and Dr. Chris Ambrose share insight on the efficacy of tezepelumab in severe, uncontrolled asthma, and baseline predictors of enhanced response which support tezepelumab as a promising biologic treatment option.
Achieving Remission with Methotrexate or TNFi Linked to Lower CV Risk in Rheumatoid ArthritisMay 31st 2023
An analysis of patient data from Sweden and Norway detail the impact of achieving remission with methotrexate or TNF inhibitors on risk of acute coronary syndrome in patients with rheumatoid arthritis.
BE VITAL: Bimekizumab Helps Control, Attenuate Disease Activity in Psoriatic ArthritisMay 31st 2023
Data from the BE VITAL OLE study, which included patients from the BE COMPLETE and BE OPTIMAL studies, suggests the benefits of bimekizumab in patients with psoriatic arthritis with inadequate response or intolerance to TNF inhibitors were sustained for up to 52 weeis.
Hollis O'Neal, MD: FDA-Approved Test Can Identify Early SepsisMay 30th 2023
Late-breaking data validates the FDA clearance of Cytovale's IntelliSep test, demonstrating its potential to aid in the early detection of sepsis in US emergency departments, with the aim of improving patient outcomes.
Hollis O'Neal, MD: Late Breaking Data on Diagnostic Test for Sepsis IntelliSepMay 29th 2023
Late-breaking data from ATS 2023 show new positive evidence of the innovative in-vitro diagnostic tool IntelliSep test that measures the viscoelastic properties of leukocytes, showing promising results for rapid sepsis diagnosis in EDs.
Victor Kim, MD: Addressing Comorbidities and Advancing COPD CareMay 28th 2023
Data indicates that addressing mood disorders in patients not only improves mood symptoms but also demonstrates positive effects on certain cardiac events, suggesting benefits for both mental and physical well-being.
Cedric Rutland, MD: Mechanisms Behind Immunology, Cellular CommunicationMay 23rd 2023
Dr. Rutland emphasizes the importance of understanding cellular communication and its potential to manipulate disease processes for patient benefit, including the observed link between ILD, inflammation, scarring, and pulmonary hypertension.
Dupilumab Improves Outcomes for COPD, Type 2 Inflammation in Randomized TrialMay 22nd 2023
Dupilumab demonstrates significant improvements in patients with COPD, type 2 inflammation by reducing exacerbations, improving lung function and quality of life, and alleviating respiratory symptoms.